PPI Regimen for Patients on Steroid Therapy

Risk Assessment and Indications for PPI Use

Patients on steroid therapy with risk factors such as age ≥65 years, previous gastrointestinal events, or concurrent use of NSAIDs, aspirin, or anticoagulants should receive a proton pump inhibitor (PPI) 1, 2, 3
Steroid therapy alone is considered a risk factor for gastrointestinal complications, with approximately a two-fold increase in gastrointestinal events compared to those not taking steroids 3
PPI co-therapy is rated as "appropriate" for patients on steroids or warfarin according to expert consensus guidelines 1, 2
The decision to use PPI prophylaxis should be based on the presence of risk factors, including age ≥65 years (2-3.5 fold increased risk) and previous gastrointestinal events (2.5-4 fold increased risk) 3
Concomitant use of NSAIDs, aspirin, or anticoagulants is also a risk factor for gastrointestinal complications 1, 2

Standard once-daily dosing of a PPI is recommended for most patients requiring gastroprotection while on steroid therapy 4
Double-dose PPIs (twice daily or double-strength) are generally not recommended and have been associated with higher risks of complications including pneumonia, hip fracture, and C. difficile infection 4

For patients with additional risk factors (age ≥65 years with previous complicated GI events AND on steroids), PPI therapy is strongly recommended 2, 3
For patients <65 years with no previous GI events and on steroids alone, PPI therapy is still considered appropriate 1, 2
When steroids are combined with NSAIDs or aspirin, PPI therapy becomes even more important due to the additive risk 1, 2, 3

PPI therapy should be continued for the duration of steroid treatment 4
After completion of steroid therapy, PPI should be discontinued unless there are other ongoing indications 4

Regular reassessment of the need for ongoing PPI therapy is recommended 4
For patients without a definitive indication for chronic PPI use beyond steroid therapy, consider de-prescribing once steroids are discontinued 4
Document the indication for PPI therapy clearly in the medical record to facilitate appropriate discontinuation when no longer needed 4